Thryve is the only monthly subscription service that combines customized testing of the microbiome with a personalized probiotic created specifically for the individual. Thryve's platform connects individuals with leading scientific research and robust online community to come together and uncover meaningful and actionable insights into tackling microbiome related diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/15/18 | $1,400,000 |
Abstract Ventures Candela Paramount Darling Ventures Joyance Partners PivotNorth Capital Unilever Ventures | undisclosed |
